Embody vs bmiMD: Low Price Semaglutide vs Tiered Tirzepatide Plans
Quick verdict: For a low, entry semaglutide price and fastest shipping after approval, Embody is the budget, no-frills option; for lower long-term tirzepatide rates with multi-month billing choices, bmiMD is the commitment-focused alternative. This comparison uses only published provider facts for Embody vs bmiMD.
See Embody pricing and sign up
How the two providers differ at a glance
Embody and bmiMD both offer clinician-reviewed, direct-pay telehealth programs with compounded GLP-1 options, but they take different approaches to price, product mix, shipping speed, and commitments. Below are the most distinctive supported differences for Embody vs bmiMD.
1) Price and product focus
Embody lists a starting semaglutide price of $69/month (was $299) and compounded tirzepatide at $119/month. bmiMD lists tirzepatide month-to-month at $179/month with multi-month plans that lower the monthly equivalent to $159 for three months, $149 for six months, and $139 for a 12-month plan. These are the published monthly figures from each provider.
Compare Embody’s $69 semaglutide offer
2) Billing commitments and long-term cost
Embody emphasizes no monthly membership, cancel anytime, and flat locked-in monthly pricing. bmiMD provides four billing options; its lowest monthly equivalent ($139/mo) requires a 12-month commitment. bmiMD highlights lower long-term monthly equivalents in exchange for multi-month commitments.
3) Medications offered and formulation notes
Embody offers compounded semaglutide and compounded tirzepatide. bmiMD is presented as offering compounded tirzepatide (GLP-1/GIP). Both sources state their compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Embody’s messaging calls out semaglutide specifically as a low entry price; bmiMD centers on tirzepatide with tiered plans.
4) Shipping and delivery
Embody advertises free shipping and delivery in 1–2 days after clinician approval. bmiMD advertises free subscription shipping on every order but does not supply the same 1–2 day delivery claim in the captured evidence. Both deliver medication to patients after online clinician review.
Check bmiMD shipping and enrollment
5) Support and clinician access
Embody notes licensed provider review handled entirely online and 24/7 support access for dosing and side-effect questions. bmiMD promotes 24/7 clinician access and online refills and delivery. Both present clinician review and online management as part of their model.
Side-by-side comparison table
| Criteria | Embody | bmiMD |
|---|---|---|
| Starting monthly price | $69/month semaglutide; $119/month tirzepatide | $179/month tirzepatide (monthly); $139/month with 12-month plan |
| Medication types | Compounded semaglutide and compounded tirzepatide | Compounded tirzepatide (GLP-1/GIP) |
| Commitments | No monthly membership; cancel anytime | Four billing options; lowest price requires 12-month commitment |
| Shipping | Free shipping; arrives in 1–2 days after approval | Free subscription shipping on every order |
| Clinician access | Licensed provider review online; 24/7 support access | 24/7 clinician access; online refills and delivery |
| Regulatory note | Compounded medications not FDA-approved | Compounded medications not FDA-approved |
What this comparison does not supply
The captured evidence does not provide comparative information on clinical outcomes, specific dosing schedules, exact turnaround times for bmiMD, state-by-state availability details beyond what is listed, or insurance coverage. Only the published facts above were used for the Embody vs bmiMD comparison.
Conclusion and who should choose which
Embody vs bmiMD comes down to whether you value the lowest possible entry price and the fastest advertised post-approval shipping, or whether you prefer lower long-term monthly equivalents in exchange for a multi-month commitment. Use the primary keyword Embody vs bmiMD when deciding which trade-offs matter most to you.
Choose Embody if…
You want a low entry price for compounded semaglutide ($69/month), a simple, cancel-anytime model, and free 1–2 day shipping after clinician approval.
Choose bmiMD if…
You are focused on tirzepatide and want lower long-term monthly equivalents through a multi-month plan (down to $139/month with a 12-month plan) and free subscription shipping with 24/7 clinician access.